Certara Q2 2025 revenue $104.6M (+12% YoY); net loss narrows to $2.0M; reiterates FY guidance

Certara, Inc.

2025-Q2 EPS reported $0.02 revenue$210,574,000

Revenue $104.6M (+12% YoY); software revenue $46.7M (+22%), services $57.9M (+5%).
Net loss improved 84% to $2.0M from $12.6M in Q2 2024.
Adjusted EBITDA $31.9M (+21% YoY); Chemaxon contributed $5.3M to revenue.
Full-year 2025 financial guidance reaffirmed, citing sustained demand for model-informed drug development.
CEO highlighted software product enhancements and new product introductions driving long-term growth.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.